Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time (scientific article published on September 2006)

Population data on the thirteen CODIS core short tandem repeat loci in African Americans, U.S. Caucasians, Hispanics, Bahamians, Jamaicans, and Trinidadians

Q30584976

Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity

Q33333698

Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City

Q33338440

Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations

Q33357666

Prognostic value of anti-dsDNA in SLE

Q33553757

Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation

Q33584094

Outcomes of self-help education for patients with arthritis

Q34198626

Sociocultural issues in clinical research

Q34233518

Ethnic-affiliation estimation by use of population-specific DNA markers

Q34421878

Measuring disease activity in systemic lupus: progress and problems.

Q34988560

Neighbourhood environments and mortality in an elderly cohort: results from the cardiovascular health study

Q35413596

Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis

Q35552732

Systemic lupus erythematosus in three ethnic groups. XVIII. Factors predictive of poor compliance with study visits

Q35743182

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

Q35822079

Predictive value of autoantibodies for activity of systemic lupus erythematosus

Q35824462

Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations

Q39236035

The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".

Q40541271

Clinical features of systemic lupus erythematosus.

Q40921570

Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans

Q41442962

SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.

Q41748151

Describing race, ethnicity, and culture in medical research

Q43187901

Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.

Q43552335

Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group

Q43589680

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

Q43772904

Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores

Q44003915

Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study

Q44909771

Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI).

Q45212503

Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture

Q46187058

Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual

Q46223662

Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture

Q46430510

Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus

Q47294051

Determinants of discordance between patients and physicians in their assessment of lupus disease activity.

Q47634366

Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage

Q47684491

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.

Q51053168

The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.

Q51987362

The effectiveness and efficiency of health promotion in specialty clinic care.

Q52206306

The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

Q52884043

Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM)

Q53369065

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

Q57740770

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

Q58161127

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians

Q58161234

Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?

Q60729418

Efficacy of psychoeducational interventions on pain, depression, and disability in people with arthritis: a meta-analysis

Q69403027

Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication study

Q70531938

Fibromyalgia syndrome and disease activity in systemic lupus erythematosus

Q72781869

The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus

Q73013000

Do lupus disease activity measures detect clinically important change?

Q73892282

Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus

Q74258702

Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture

Q74776728

An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study

Q77375225

Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group

Q77444828

DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q

Q78108912

Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course

Q80181279

A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus

Q80181322

Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE

Q81710052

The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index

Q93618721

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

systemic lupus erythematosus

Q1485

multiethnicity

Q111242702

P304

page(s)

1168-1174

P577

publication date

2006-09-01

P1433

published in

Annals of the Rheumatic Diseases

Q4767876

P1476

title

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

P478

volume

Reverse relations

cites work (P2860)

Q36162841	A study of racial/ethnic differences in treatment preferences among lupus patients
Q55314394	Analysis of clinical risk factors in relapsed patients with class IV lupus nephritis.
Q37133875	Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study
Q34110676	Association of systemic lupus erythematosus clinical features with European population genetic substructure.
Q39346785	Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry
Q30715531	Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States
Q35170761	Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California
Q37095704	Clinical expression and course in patients with late onset systemic lupus erythematosus
Q34226560	Creating musculoskeletal programs for culturally diverse, underserved communities: a community-based participatory research survey.
Q35156880	Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
Q36709105	Development and validation of a simple lupus severity index using ACR criteria for classification of SLE.
Q37228138	Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary
Q36740011	Disruptions in energy balance: does nature overcome nurture?
Q58620300	Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
Q53839415	Epidemiology of systemic lupus erythematosus.
Q33380972	Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort
Q58870327	ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes
Q36313012	Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort
Q38549420	Lupus (SLE): Existence and Impact of Depressive Symptomatology
Q35992226	Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study
Q81563984	Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups
Q59808159	Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort
Q37659608	Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.
Q48636445	Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Q47674141	Relatives' quality of life and psychological disturbance: a new concern of SLE management
Q36084221	Social Support and Self-Reported Stress Levels in a Predominantly African American Sample of Women with Systemic Lupus Erythematosus
Q37327039	Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus
Q34017775	Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study
Q37921757	Systemic lupus erythematosus in Hispanics
Q35638310	Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability
Q38936647	The global burden of SLE: prevalence, health disparities and socioeconomic impact
Q33871748	The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus
Q90048328	Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity
Q33621131	Understanding the epidemiology and progression of systemic lupus erythematosus
Q35848834	Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: a pilot study
Q37137321	Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort
Q34744620	Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus

P356	DOI	10.1136/ARD.200X.046896
P932	PMC publication ID	1798273
P698	PubMed publication ID	16905579